The interaction between coumarin drugs and DNA gyrase

Mol Microbiol. 1993 Aug;9(4):681-6. doi: 10.1111/j.1365-2958.1993.tb01728.x.

Abstract

The coumarin group of antibiotics have as their target the bacterial enzyme DNA gyrase. The drugs bind to the B subunit of gyrase and inhibit DNA supercoiling by blocking the ATPase activity. Recent data show that the binding site for the drugs lies within the N-terminal part of the B protein, and individual amino acids involved in coumarin interaction are being identified. The mode of inhibition of the gyrase ATPase reaction by coumarins is unlikely to be simple competitive inhibition, and the drugs may act by stabilizing a conformation of the enzyme with low affinity for ATP.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Adenosine Triphosphatases / antagonists & inhibitors
  • Aminocoumarins
  • Bacterial Proteins / antagonists & inhibitors*
  • Bacterial Proteins / chemistry
  • Bacterial Proteins / genetics
  • Bacterial Proteins / metabolism
  • Binding Sites
  • Coumarins / metabolism
  • Coumarins / pharmacology
  • DNA Topoisomerases, Type II / chemistry
  • DNA Topoisomerases, Type II / genetics
  • DNA Topoisomerases, Type II / metabolism
  • DNA, Bacterial / metabolism
  • DNA, Superhelical / metabolism
  • Escherichia coli / enzymology
  • Escherichia coli / genetics
  • Models, Molecular
  • Novobiocin / analogs & derivatives*
  • Novobiocin / metabolism
  • Novobiocin / pharmacology*
  • Protein Binding
  • Protein Structure, Tertiary*
  • Structure-Activity Relationship
  • Topoisomerase II Inhibitors*

Substances

  • Aminocoumarins
  • Bacterial Proteins
  • Coumarins
  • DNA, Bacterial
  • DNA, Superhelical
  • Topoisomerase II Inhibitors
  • Novobiocin
  • clorobiocin
  • Adenosine Triphosphatases
  • DNA Topoisomerases, Type II
  • coumermycin